348 related articles for article (PubMed ID: 34523963)
21. Characterization of a Cell Culture System of Persistent Hepatitis E Virus Infection in the Human HepaRG Hepatic Cell Line.
Pellerin M; Hirchaud E; Blanchard Y; Pavio N; Doceul V
Viruses; 2021 Mar; 13(3):. PubMed ID: 33806591
[TBL] [Abstract][Full Text] [Related]
22. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
23. Molecular virology of hepatitis E virus.
Ahmad I; Holla RP; Jameel S
Virus Res; 2011 Oct; 161(1):47-58. PubMed ID: 21345356
[TBL] [Abstract][Full Text] [Related]
24. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma.
Sayed IM; Foquet L; Verhoye L; Abravanel F; Farhoudi A; Leroux-Roels G; Izopet J; Meuleman P
Antiviral Res; 2017 May; 141():150-154. PubMed ID: 28232247
[TBL] [Abstract][Full Text] [Related]
25. Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein.
Szkolnicka D; Pollán A; Da Silva N; Oechslin N; Gouttenoire J; Moradpour D
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315997
[TBL] [Abstract][Full Text] [Related]
26. Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion.
Gouttenoire J; Pollán A; Abrami L; Oechslin N; Mauron J; Matter M; Oppliger J; Szkolnicka D; Dao Thi VL; van der Goot FG; Moradpour D
PLoS Pathog; 2018 Dec; 14(12):e1007471. PubMed ID: 30532200
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces.
Takahashi M; Yamada K; Hoshino Y; Takahashi H; Ichiyama K; Tanaka T; Okamoto H
Arch Virol; 2008; 153(9):1703-13. PubMed ID: 18679765
[TBL] [Abstract][Full Text] [Related]
28. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
[TBL] [Abstract][Full Text] [Related]
29. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
30. Dissecting the potential role of hepatitis E virus ORF1 nonstructural gene in cross-species infection by using intergenotypic chimeric viruses.
Tian D; Yugo DM; Kenney SP; Lynn Heffron C; Opriessnig T; Karuppannan AK; Bayne J; Halbur PG; Meng XJ
J Med Virol; 2020 Dec; 92(12):3563-3571. PubMed ID: 32589758
[TBL] [Abstract][Full Text] [Related]
31. Multivesicular body sorting and the exosomal pathway are required for the release of rat hepatitis E virus from infected cells.
Primadharsini PP; Nagashima S; Takahashi M; Kobayashi T; Nishiyama T; Nishizawa T; Yasuda J; Mulyanto ; Okamoto H
Virus Res; 2020 Mar; 278():197868. PubMed ID: 31962066
[TBL] [Abstract][Full Text] [Related]
32. A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
Wang H; Ji F; Liang H; Gu H; Ning Z; Liu R; Zhang G
PLoS One; 2015; 10(7):e0133282. PubMed ID: 26177202
[TBL] [Abstract][Full Text] [Related]
33. [Cell culture system for hepatitis E virus].
Okamoto H
Uirusu; 2010 Jun; 60(1):93-104. PubMed ID: 20848869
[TBL] [Abstract][Full Text] [Related]
34. Ectopic Expression of Genotype 1 Hepatitis E Virus ORF4 Increases Genotype 3 HEV Viral Replication in Cell Culture.
Yadav KK; Boley PA; Fritts Z; Kenney SP
Viruses; 2021 Jan; 13(1):. PubMed ID: 33430442
[TBL] [Abstract][Full Text] [Related]
35. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
[TBL] [Abstract][Full Text] [Related]
36. Culture systems for hepatitis E virus.
Okamoto H
J Gastroenterol; 2013 Feb; 48(2):147-58. PubMed ID: 23104469
[TBL] [Abstract][Full Text] [Related]
37. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions.
Nagashima S; Takahashi M; Jirintai S; Tanaka T; Nishizawa T; Yasuda J; Okamoto H
J Gen Virol; 2011 Dec; 92(Pt 12):2838-2848. PubMed ID: 21880841
[TBL] [Abstract][Full Text] [Related]
38. Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood.
Okamoto H
Rev Med Virol; 2011 Jan; 21(1):18-31. PubMed ID: 21294213
[TBL] [Abstract][Full Text] [Related]
39. Treatment induced clearance of hepatitis E viruses by interferon-lambda in liver-humanized mice.
Sari G; Mulders CE; Zhu J; van Oord GW; Feng Z; Kreeft-Voermans JJC; Boonstra A; Vanwolleghem T
Liver Int; 2021 Dec; 41(12):2866-2873. PubMed ID: 34392598
[TBL] [Abstract][Full Text] [Related]
40. The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte.
Tyagi S; Surjit M; Roy AK; Jameel S; Lal SK
J Biol Chem; 2004 Jul; 279(28):29308-19. PubMed ID: 15037615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
